502 related articles for article (PubMed ID: 23715726)
1. Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.
Ushio M; Nishio Y; Sekine O; Nagai Y; Maeno Y; Ugi S; Yoshizaki T; Morino K; Kume S; Kashiwagi A; Maegawa H
Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E293-304. PubMed ID: 23715726
[TBL] [Abstract][Full Text] [Related]
2. The Niemann-Pick C1 like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice.
Sugizaki T; Watanabe M; Horai Y; Kaneko-Iwasaki N; Arita E; Miyazaki T; Morimoto K; Honda A; Irie J; Itoh H
Endocrinology; 2014 Aug; 155(8):2810-9. PubMed ID: 24773344
[TBL] [Abstract][Full Text] [Related]
3. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
[TBL] [Abstract][Full Text] [Related]
4. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
[TBL] [Abstract][Full Text] [Related]
5. Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice.
Wang X; Ren Q; Wu T; Guo Y; Liang Y; Liu S
Mol Med Rep; 2014 Dec; 10(6):2917-23. PubMed ID: 25310357
[TBL] [Abstract][Full Text] [Related]
6. Ezetimibe increases hepatic iron levels in mice fed a high-fat diet.
Kishino Y; Tanaka Y; Ikeda T; Yamamoto K; Ogawa H; Iwatani Y; Kamisako T
J Pharmacol Exp Ther; 2013 Jun; 345(3):483-91. PubMed ID: 23538201
[TBL] [Abstract][Full Text] [Related]
7. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats.
Crescenzo R; Bianco F; Coppola P; Mazzoli A; Tussellino M; Carotenuto R; Liverini G; Iossa S
Exp Physiol; 2014 Sep; 99(9):1203-13. PubMed ID: 24972835
[TBL] [Abstract][Full Text] [Related]
8. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
9. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein.
Yamazaki T; Kishimoto K; Miura S; Ezaki O
J Nutr Biochem; 2012 Feb; 23(2):123-32. PubMed ID: 21447441
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
11. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet.
Wada T; Kenmochi H; Miyashita Y; Sasaki M; Ojima M; Sasahara M; Koya D; Tsuneki H; Sasaoka T
Endocrinology; 2010 May; 151(5):2040-9. PubMed ID: 20211973
[TBL] [Abstract][Full Text] [Related]
12. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
13. [Activation of Kupffer cell and related signal pathway proteins in the liver of high fat and high fructose diet induced NAFLD mice].
Zhu ML; Liu J; Liu YL; Yang WJ; Luo Y; Zhuang ZJ; Jiao QB; Chen JY; Yan J; Bian DX; Ma XJ; Xun YH; Shi JP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Oct; 27(5):325-7. PubMed ID: 24645313
[TBL] [Abstract][Full Text] [Related]
14. Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet.
Wada T; Miyashita Y; Sasaki M; Aruga Y; Nakamura Y; Ishii Y; Sasahara M; Kanasaki K; Kitada M; Koya D; Shimano H; Tsuneki H; Sasaoka T
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1415-25. PubMed ID: 24129399
[TBL] [Abstract][Full Text] [Related]
15. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT
Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913
[TBL] [Abstract][Full Text] [Related]
16. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
Kim S; Hong J; Jeon R; Kim HS
Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
[TBL] [Abstract][Full Text] [Related]
17. Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice.
Santos IB; de Bem GF; Cordeiro VSC; da Costa CA; de Carvalho LCRM; da Rocha APM; da Costa GF; Ognibene DT; de Moura RS; Resende AC
Nutr Res; 2017 Jul; 43():69-81. PubMed ID: 28739056
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
[TBL] [Abstract][Full Text] [Related]
19. Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function.
Valdecantos MP; Pérez-Matute P; González-Muniesa P; Prieto-Hontoria PL; Moreno-Aliaga MJ; Martínez JA
J Nutr Biochem; 2012 Dec; 23(12):1676-84. PubMed ID: 22464149
[TBL] [Abstract][Full Text] [Related]
20. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time.
Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I
J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]